tirzepatide weight loss clinical trial results once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo- controlled, phase 3 Tirzepatide for Medical Weight Loss

Food and Drug Administration (FDA) has approved to treat type 2 diabetes, Rybelsus is available in pill form and taken once a day

If nausea is significant, knowing which foods work best on semaglutide can make a real difference

Glucagon-like peptide 1 reduces appetite after a meal, in that case, if the body releases less of this hormone, individuals may eat more during a meal and are more likely to snack between meals

Although cholecystitis has been reported, large outcome trials have not substantiated pancreatitis signals, and current evidence does not indicate increased risks of infection or obesity-related cancers

Clinicians may compensate by considering diabetes as equivalent to rheumatoid arthritis in the FRAX calculation, adjusting T-scores downward, or using lower intervention thresholds for patients with diabetes

Monitor your blood sugar levels regularly